Travere Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

SAN DIEGO, Feb. 24, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2021 financial results and provided a corporate update.

Read the full press release >

Travere Therapeutics Recognizes Rare Disease Day 2022 and Raises Awareness for People Living with Rare Disease